Tandem Diabetes Care | TNDM - Ebit

Stock Price
20.36
Daily Change
-0.32 -1.55%
Monthly
-16.08%
Yearly
12.74%
Q2 Forecast
19.92

Tandem Diabetes Care reported $8.29M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Abbott USD 1.85B 684M Mar/2026
Accuray USD 11.38M 12.71M Sep/2024
Align Technology USD 224.71M 40.06M Dec/2025
AtriCure USD 2.49M 2.28M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Eli Lilly USD 8.99B 1.57B Dec/2025
Globus Medical USD 181.31M 298.83M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
Intuitive Surgical USD 859.7M 5.6M Mar/2026
J&J USD 6.62B 1.51B Mar/2026
Masimo USD 83.9M 200K Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Orthofix International USD 6.12M 1.91M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 76.31M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025